Literature DB >> 32886293

A multivariate model of time to conversion from mild cognitive impairment to Alzheimer's disease.

María Eugenia López1,2,3,4, Agustín Turrero5,6, Pablo Cuesta7,8, Inmaculada Concepción Rodríguez-Rojo8,9,10, Ana Barabash5,11, Alberto Marcos5,12, Fernando Maestú7,8,13,5, Alberto Fernández8,5,14.   

Abstract

The present study was aimed at determining which combination of demographic, genetic, cognitive, neurophysiological, and neuroanatomical factors may predict differences in time to progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD). To this end, a sample of 121 MCIs was followed up during a 5-year period. According to their clinical outcome, MCIs were divided into two subgroups: (i) the "progressive" MCI group (n = 46; mean time to progression 17 ± 9.73 months) and (ii) the "stable" MCI group (n = 75; mean time of follow-up 31.37 ± 14.58 months). Kaplan-Meier survival analyses were applied to explore each variable's relationship with the progression to AD. Once potential predictors were detected, Cox regression analyses were utilized to calculate a parsimonious model to estimate differences in time to progression. The final model included three variables (in order of relevance): left parahippocampal volume (corrected by intracranial volume, LP_ ICV), delayed recall (DR), and left inferior occipital lobe individual alpha peak frequency (LIOL_IAPF). Those MCIs with LP_ICV volume, DR score, and LIOL_IAPF value lower than the defined cutoff had 6 times, 5.5 times, and 3 times higher risk of progression to AD, respectively. Besides, when the categories of the three variables were "unfavorable" (i.e., values below the cutoff), 100% of cases progressed to AD at the end of follow-up. Our results highlighted the relevance of neurophysiological markers as predictors of conversion (LIOL_IAPF) and the importance of multivariate models that combine markers of different nature to predict time to progression from MCI to dementia.

Entities:  

Keywords:  Alzheimer’s disease; Delayed recall; Episodic memory; Individual alpha peak frequency; Medial–temporal volume; Mild cognitive impairment; Time to progression

Mesh:

Substances:

Year:  2020        PMID: 32886293      PMCID: PMC7732920          DOI: 10.1007/s11357-020-00260-7

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.713


  111 in total

Review 1.  EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis.

Authors:  W Klimesch
Journal:  Brain Res Brain Res Rev       Date:  1999-04

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function.

Authors:  T R Stoub; E J Rogalski; S Leurgans; D A Bennett; L deToledo-Morrell
Journal:  Neurobiol Aging       Date:  2008-09-21       Impact factor: 4.673

4.  The posterior parahippocampal gyrus is preferentially affected in age-related memory decline.

Authors:  S Burgmans; M P J van Boxtel; K E M van den Berg; E H B M Gronenschild; H I L Jacobs; J Jolles; H B M Uylings
Journal:  Neurobiol Aging       Date:  2009-10-30       Impact factor: 4.673

5.  Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.

Authors:  Simon F Eskildsen; Pierrick Coupé; Vladimir S Fonov; Jens C Pruessner; D Louis Collins
Journal:  Neurobiol Aging       Date:  2014-08-28       Impact factor: 4.673

6.  Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease.

Authors:  V Jelic; S E Johansson; O Almkvist; M Shigeta; P Julin; A Nordberg; B Winblad; L O Wahlund
Journal:  Neurobiol Aging       Date:  2000 Jul-Aug       Impact factor: 4.673

7.  Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot study.

Authors:  H W Berendse; J P Verbunt; P Scheltens; B W van Dijk; E J Jonkman
Journal:  Clin Neurophysiol       Date:  2000-04       Impact factor: 3.708

8.  Higher atrophy rate of entorhinal cortex than hippocampus in AD.

Authors:  A T Du; N Schuff; J H Kramer; S Ganzer; X P Zhu; W J Jagust; B L Miller; B R Reed; D Mungas; K Yaffe; H C Chui; M W Weiner
Journal:  Neurology       Date:  2004-02-10       Impact factor: 9.910

Review 9.  Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders.

Authors:  Robert W Mahley
Journal:  J Mol Med (Berl)       Date:  2016-06-09       Impact factor: 4.599

10.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

Authors:  J C Lambert; C A Ibrahim-Verbaas; D Harold; A C Naj; R Sims; C Bellenguez; A L DeStafano; J C Bis; G W Beecham; B Grenier-Boley; G Russo; T A Thorton-Wells; N Jones; A V Smith; V Chouraki; C Thomas; M A Ikram; D Zelenika; B N Vardarajan; Y Kamatani; C F Lin; A Gerrish; H Schmidt; B Kunkle; M L Dunstan; A Ruiz; M T Bihoreau; S H Choi; C Reitz; F Pasquier; C Cruchaga; D Craig; N Amin; C Berr; O L Lopez; P L De Jager; V Deramecourt; J A Johnston; D Evans; S Lovestone; L Letenneur; F J Morón; D C Rubinsztein; G Eiriksdottir; K Sleegers; A M Goate; N Fiévet; M W Huentelman; M Gill; K Brown; M I Kamboh; L Keller; P Barberger-Gateau; B McGuiness; E B Larson; R Green; A J Myers; C Dufouil; S Todd; D Wallon; S Love; E Rogaeva; J Gallacher; P St George-Hyslop; J Clarimon; A Lleo; A Bayer; D W Tsuang; L Yu; M Tsolaki; P Bossù; G Spalletta; P Proitsi; J Collinge; S Sorbi; F Sanchez-Garcia; N C Fox; J Hardy; M C Deniz Naranjo; P Bosco; R Clarke; C Brayne; D Galimberti; M Mancuso; F Matthews; S Moebus; P Mecocci; M Del Zompo; W Maier; H Hampel; A Pilotto; M Bullido; F Panza; P Caffarra; B Nacmias; J R Gilbert; M Mayhaus; L Lannefelt; H Hakonarson; S Pichler; M M Carrasquillo; M Ingelsson; D Beekly; V Alvarez; F Zou; O Valladares; S G Younkin; E Coto; K L Hamilton-Nelson; W Gu; C Razquin; P Pastor; I Mateo; M J Owen; K M Faber; P V Jonsson; O Combarros; M C O'Donovan; L B Cantwell; H Soininen; D Blacker; S Mead; T H Mosley; D A Bennett; T B Harris; L Fratiglioni; C Holmes; R F de Bruijn; P Passmore; T J Montine; K Bettens; J I Rotter; A Brice; K Morgan; T M Foroud; W A Kukull; D Hannequin; J F Powell; M A Nalls; K Ritchie; K L Lunetta; J S Kauwe; E Boerwinkle; M Riemenschneider; M Boada; M Hiltuenen; E R Martin; R Schmidt; D Rujescu; L S Wang; J F Dartigues; R Mayeux; C Tzourio; A Hofman; M M Nöthen; C Graff; B M Psaty; L Jones; J L Haines; P A Holmans; M Lathrop; M A Pericak-Vance; L J Launer; L A Farrer; C M van Duijn; C Van Broeckhoven; V Moskvina; S Seshadri; J Williams; G D Schellenberg; P Amouyel
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

View more
  3 in total

1.  Episodic memory dysfunction and hypersynchrony in brain functional networks in cognitively intact subjects and MCI: a study of 379 individuals.

Authors:  Brenda Chino; Pablo Cuesta; Javier Pacios; Jaisalmer de Frutos-Lucas; Lucía Torres-Simón; Sandra Doval; Alberto Marcos; Ricardo Bruña; Fernando Maestú
Journal:  Geroscience       Date:  2022-09-15       Impact factor: 7.581

2.  Gamma band functional connectivity reduction in patients with amnestic mild cognitive impairment and epileptiform activity.

Authors:  Pablo Cuesta; Manuela Ochoa-Urrea; Michael Funke; Omar Hasan; Ping Zhu; Alberto Marcos; Maria Eugenia López; Paul E Schulz; Samden Lhatoo; Dimitrios Pantazis; John C Mosher; Fernando Maestu
Journal:  Brain Commun       Date:  2022-02-03

3.  Sex differences in brain functional connectivity of hippocampus in mild cognitive impairment.

Authors:  Jordan Williamson; Andriy Yabluchanskiy; Peter Mukli; Dee H Wu; William Sonntag; Carrie Ciro; Yuan Yang
Journal:  Front Aging Neurosci       Date:  2022-08-10       Impact factor: 5.702

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.